Platelet–lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome

Journal of Thrombosis and Thrombolysis

Volumn 39, Issue 2, 2015, Pages 179-185

  Koseoglu, Handan Inonu ^a   Altunkas, Fatih ^a   Kanbay, Asiye ^b   Doruk, Sibel ^a   Etikan, Ilker ^a   Demir, Osman ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

Author keywords

Cardiovascular disease; Obstructive sleep apnea syndrome; Platelet lymphocyte ratio

Indexed keywords

ADULT; ANOXIA; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPLICATION; FEMALE; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; STATISTICS; STATISTICS AND NUMERICAL DATA; THROMBOCYTE COUNT; TURKEY;

ADULT; ANOXIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; OXIDATIVE STRESS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC; TURKEY;

EID: 84939884762     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1103-4     Document Type: Article

References (40)

1. McNicholas WT, Bonsigore MR (2007) Management committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence basic and research priorities. Eur Respir J 29(1):156–178
2. Weiss JW, Launois SH, Anand A, Garpestad E (1999) Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis 41(5):367–376
3. Yang WS, Lee WJ, Funahashi T et al (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86(8):3815–3819
4. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A (2004) Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27(10):2450–2457
5. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7(12):677–685
6. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J 85(1010):693–698
7. Jennings LK (2009) Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102(2):248–257
8. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP (2003) Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9(3):177–190
9. Dotsenko O, Chaturvedi N, Thom SA et al (2007) Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J Thromb Haemost 5(10):2036–2042
10. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22(5):667–689
11. Iber C, Ancoli-Israel S, Chesson A, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specification, 1st edn. American Academy of Sleep Medicine, Westchester
12. EEG arousals: scoring rules and examples: a preliminary report from the sleep disorders Atlas task force of the American sleep disorders relationship. Sleep 1992; 15(2):173–184
13. Williams MS (2012) Platelets and depression in cardiovascular disease: a brief review of the current literature. World J Psychiatry 2(6):114–123
14. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84(2):613–617
15. Stissing T, Dridi NP, Ostrowski SR, Bochsen L, Johansson PI (2011) The influence of lowplatelet count onwhole blood aggregometry assessed by Multiplate. Clin Appl Thromb Hemost 17(6):211–217
16. Iijima R, Ndrepepa G, Mehilli J et al (2007) Relationship between platelet count and 30 day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost 98(4):852–857
17. Nikolsky E, Grines CL, Cox DA et al (2007) Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 99(8):1055–1061
18. Vidwan P, Lee S, Rossi JS, Stouffer GA (2010) Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography. Am J Cardiol 105(9):1219–1222
19. Hung J, Whitford EG, Parsons RW, Hillman DR (1990) Association of sleep apnoea with myocardial infarction in men. Lancet 336(8710):261–264
20. Peker Y, Hedner J, Kraiczi H, Löth S (2000) Respiratory disturbance index: an independent predictor of mortality in coonary artery disease. Am J Respir Crit Care Med 162(1):81–86
21. Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB (1996) Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27(3):401–407
22. Bassetti C, Aldrich MS (1999) Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 22(2):217–223
23. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384
24. Grunstein RR, Stenlof K, Hedner J, Sjostrom L (1995) Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the swedish obese subjects (SOS) study. Int J Obes Relat Metab Disord 19(6):410–418
25. Kashyap R, Hock LM, Bowman TJ (2001) Higher prevalence of smoking in patients diagnosed as having obstructive sleep apnea. Sleep Breath 5(4):167–172
26. Shepard JW Jr (1992) Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 13(3):437–458
27. Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen J (1996) Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5(1):42–50
28. Takama N, Kurabayasi M (2009) Influence of untreated sleep disordered breathing on the longterm prognosis of patients with cardiovascular disease. Am J Cardiol 103(5):730–734
29. Imhof BA, Aurrand-Lions M (2006) Angiogenesis and inflammation face off. Nat Med 12(2):171–172
30. Horne BD, Anderson JL, John JM et al (2005) Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45(10):1638–1643
31. Azab B, Shah N, Akerman M, McGinnJr JT (2012) Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-STelevation myocardial infarction. J Thromb Thrombolysis 34(3):326–334
32. Sunbul M, Gerin F, Durmus E et al (2013) Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens. doi:10.3109/10641963.2013.804547
33. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M (2002) In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69(3):229–234
34. Hui DS, Ko FW, Fok JP et al (2004) The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125(5):1768–1775
35. Minoguchi K, Yokoe T, Tazaki T et al (2007) Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 175(6):612–617
36. Varol E, Ozturk O, Gonca T et al (2010) Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 70(7):497–502
37. Nena E, Papanas N, Steiropoulos P et al (2012) Mean platelet volume and platelet distribution width in nondiabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 23(6):447–454
38. Widmer A, Linka AZ, Attenhofer Jost CH et al (2003) Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiolog 99(1):25–31
39. Acanfora D, Gheorghiade M, Trojano L et al (2001) Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 142(1):167–173
40. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP (1997) Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 79(6):812–814